Quick Resources

  Online Support Group & Forum
  Find Doctor / Treatment Center
  Helpful Forms & Charts
  Symptoms
  Therapies
  Diet / Iron Content In Foods
  Genetics

Update on oral iron chelator deferiprone



Update on oral iron chelator deferiprone

Update on iron chelator deferiprone

The US Food and Drug Administration (FDA)'s Oncologic Drugs Advisory Committee has voted 10-2 in support of accelerated approval for second-line use of the iron chelator deferiprone (Ferriprox film-coated tablets; ApoPharma, Inc) in patients with transfusional hemosiderosis (iron overload). The application will now go to the full FDA for consideration, with a decision expected by October 14, 2011. Read more: